Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD19 Antikörper

CD19 Reaktivität: Human WB, IHC, ELISA Monoclonal unconjugated
Produktnummer ABIN965770
  • Target Alle CD19 Antikörper anzeigen
    CD19 (CD19 Molecule (CD19))
    Reaktivität
    • 301
    • 167
    • 41
    • 31
    • 19
    • 10
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Human
    Wirt
    Bitte anfragen
    Klonalität
    • 257
    • 122
    • 2
    Monoklonal
    Konjugat
    • 127
    • 26
    • 23
    • 23
    • 20
    • 10
    • 9
    • 8
    • 8
    • 7
    • 6
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser CD19 Antikörper ist unkonjugiert
    Applikation
    • 266
    • 123
    • 75
    • 73
    • 52
    • 50
    • 23
    • 21
    • 14
    • 14
    • 10
    • 10
    • 9
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    Spezifität
    Ni-NTA purified recombinant human CD19 expressed in E. Coli strain M15.
    Aufreinigung
    Antibodies are purified by protein A affinity chromatography
    Isotyp
    IgG2a
    Top Product
    Discover our top product CD19 Primärantikörper
  • Applikationshinweise
    Western Blot: Dilution 1: 2000- 5,000
    IHC(P): Dilution 1: 100- 1: 400
    IHC(F): Dilution 1: 200- 1: 400
    ELISA: Propose dilution 1: 10,000.
    Determining optimal working dilutions by titration test.
    Determining optimal working dilutions by titration test.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Lagerung
    -20 °C
  • de Rie, Zeijlemaker, von dem Borne: "Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies." in: Leukemia research, Vol. 12, Issue 2, pp. 135-41, (1988) (PubMed).

    De Rie, Zeijlemaker, Von dem Borne, Out: "Evaluation of a method of production and purification of monoclonal antibodies for clinical applications." in: Journal of immunological methods, Vol. 102, Issue 2, pp. 187-93, (1987) (PubMed).

  • Target
    CD19 (CD19 Molecule (CD19))
    Andere Bezeichnung
    CD19 (CD19 Produkte)
    Synonyme
    B4 antikoerper, CVID3 antikoerper, AW495831 antikoerper, CD19 antikoerper, CD19 molecule antikoerper, CD19 antigen antikoerper, CD19 antikoerper, Cd19 antikoerper
    Hintergrund
    The CD19 antigen (95kDa) is expressed from the earliest stage of B progenitor development, on all peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition will influence B cell activation and proliferation.
    Gen-ID
    930
    Pathways
    Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung
Sie sind hier:
Kundenservice